الفهرس 
Introduction and RationaleOnly 14 pages are availabe for public view
 |  | from | 129 |  |  |
| | | from | 129 | | |
Abstract
AKI is a widespread and dangerous issue that affects millions and leaves many
people dead or disabled. It is characterized by a sudden decline in renal function that
causes an accumulation of nitrogenous waste products and, frequently, a decrease in urine
output. COVID-19 is an infectious disease caused by (SARS-CoV-2 virus). Most
individuals affected with the virus will have mild to moderate respiratory symptoms and
recover without the need for special treatment. Nevertheless, some people will become
seriously ill and require medical care. Despite receiving little attention, AKI is one of the
most significant COVID-19 consequences. Numerous studies have examined the
incidence of AKI among COVID-19 patients in various contexts. However,
understanding of AKI risk factors and outcomes are not completely focused on in the
literature, especially in Egypt. The main goal of this study is, evaluating the incidence of
AKI in COVID-19 patients, showing the most common outcomes, and shedding the light
on the associated risk factors.
This study is a retrospective observational study conducted on 296 patients in
Isolation unit in Suez Canal University Hospital, Ismailia governorate, Egypt, in the
period between Feb 1, 2022, and Aug 1, 2022. Additionally, Patients, who were included;
had a COVID-19 infection confirmed by a positive PCR test, who are 18 years of age or
older, admitted to Suez Canal University Hospital, and are willing to accept to be
interviewed throughout the study. Collected data included the following:
• Sociodemographic characteristics (age, gender, and chronic illnesses).
• Cardiorespiratory parameters (oxygen saturation on room air, oxygen supply need,
need for MV in ICU patients, and use of cardiac support).
• Baseline investigations (total leucocytic count, lymphocytic count, NLR, serum
Na+, serum K+, preexisting baseline SCr, and preexisting eGFR).
Chapter 6: Summary